- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-06-0003367

About Pramodini Medicare Limited
Data last updated:
Pramodini Medicare Limited is a public limited company based in Vijayawada, Andhra Pradesh, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 12 September 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U85110AP2000PLC035231. Its GSTIN is 37AACCP0383J2ZA (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on NSE: PRAMODINI.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹22.05 Cr. It was formerly known as Pramodini Medicare Private Limited. It is led by directors including Kuldeep Chalasani Kumar (Managing Director) and Kavitha Chalasani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at D.No: – 29 – 4 – 54K Csi Complex Prakasam Road Suryaraopet, Vijayawada, Andhra Pradesh, India – 520002.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹62.29 Cr, a growth of 62.9% compared to the previous year. For the same year it recorded a net profit of ₹17.38 Cr (net margin 27.9%) and EBITDA of ₹30.9 Cr (EBITDA margin 49.6%). The net worth stands at ₹53.15 Cr (up 48.6% YoY). Total assets are valued at ₹71.4 Cr (up 52.1% YoY).
The company has about 19 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹53.25 Cr and satisfied charges of ₹26.91 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 1 case is pending. The company has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹1.16 Cr; the latest was in August 2026.
Pramodini Medicare Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-06-0003367). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pramodini-medicare-pvt-ltd-vijayawada.business.site.
Company details
CIN history
Pramodini Medicare has one previous CIN (Corporate Identification Number): U85110AP2000PTC035231. The current CIN is U85110AP2000PLC035231, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110AP2000PLC035231 | Current |
| U85110AP2000PTC035231 | Previous |
Recognitions & Rankings of Pramodini Medicare
Contact details
Pramodini Medicare Limited's registered office is in Vijayawada, Andhra Pradesh.
- Social Media
- Registered AddressD.No: – 29 – 4 – 54K Csi Complex Prakasam Road Suryaraopet, Vijayawada, Andhra Pradesh, India – 520002
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pramodini Medicare is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Pramodini Medicare Limited, buy the company report.
Financials of Pramodini Medicare Limited
FY 2025-26 filings availablePramodini Medicare Limited reported revenue of ₹62.29 Cr (up 62.9% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Income statement | |||
| Revenue | 62.29 | 38.24 | 35.23 |
| Revenue growth | +62.9% | +8.5% | - |
| EBITDA | 30.90 | 20.97 | 15.54 |
| EBITDA margin | +49.6% | +54.8% | +44.1% |
| Profit before tax | 23.30 | 15.76 | 10.08 |
| Net profit | 17.38 | 11.04 | 6.93 |
| Net profit margin | +27.9% | +28.9% | +19.7% |
| EPS (₹) | 10.41 | 85.87 | 5.40 |
| Balance sheet | |||
| Total assets | 71.40 | 46.95 | 37.05 |
| Net worth | 53.15 | 35.77 | 24.74 |
| Total debt | 17.85 | 10.81 | 11.96 |
| Cash & bank | 6.44 | 7.12 | 3.42 |
| Net working capital | 10.86 | 9.85 | 10.66 |
| Cash flow | |||
| Cash from operations | 25.39 | 22.12 | 9.85 |
| Cash from investing | (30.63) | (14.66) | (1.38) |
| Cash from financing | 5.73 | (2.39) | (10.81) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Income statement | |||
| Revenue | 62.29 | 38.24 | 35.23 |
| Revenue growth | +62.9% | +8.5% | - |
| EBITDA | 30.90 | 20.86 | 15.33 |
| EBITDA margin | +49.6% | +54.6% | +43.5% |
| Profit before tax | 23.30 | 15.65 | 9.87 |
| Net profit | 17.38 | 11.01 | 6.87 |
| Net profit margin | +27.9% | +28.8% | +19.5% |
| EPS (₹) | 10.41 | 85.63 | 5.35 |
| Balance sheet | |||
| Total assets | 71.27 | 46.82 | 36.95 |
| Net worth | 53.01 | 35.64 | 24.64 |
| Total debt | 17.85 | 10.81 | 11.96 |
| Cash & bank | 6.44 | 7.12 | 3.42 |
| Net working capital | 10.86 | 9.48 | 10.34 |
| Cash flow | |||
| Cash from operations | 25.39 | 22.18 | 10.00 |
| Cash from investing | (30.63) | (14.72) | (1.53) |
| Cash from financing | 5.73 | (2.39) | (10.81) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue | 62.29 | 38.24 | 35.23 |
| Revenue growth | +62.9% | +8.5% | - |
| Other income | 1.09 | 0.31 | 0.56 |
| Total expenses | 31.39 | 17.27 | 19.69 |
| Employee cost | 10.74 | 4.09 | 5.00 |
| EBITDA | 30.90 | 20.97 | 15.54 |
| EBITDA margin | +49.6% | +54.8% | +44.1% |
| Depreciation | 7.39 | 4.28 | 4.39 |
| Interest | 1.30 | 1.24 | 1.63 |
| Profit before tax | 23.30 | 15.76 | 10.08 |
| Tax | 5.92 | 4.61 | 2.94 |
| Net profit | 17.38 | 11.04 | 6.93 |
| Net profit margin | +27.9% | +28.9% | +19.7% |
| EPS (₹) | 10.41 | 85.87 | 5.40 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 16.69 | 1.28 | 1.28 |
| Reserves & surplus | 36.46 | 34.49 | 23.46 |
| Shareholders' funds (net worth) | 53.15 | 35.77 | 24.74 |
| Minority interest | 0.00 | 0.00 | 0.00 |
| Secured loans | 17.85 | 10.81 | 11.04 |
| Unsecured loans | 0.00 | 0.00 | 0.92 |
| Total debt | 17.85 | 10.81 | 11.96 |
| Total liabilities | 71.40 | 46.95 | 37.05 |
| Assets | |||
| Gross block | 86.65 | 56.84 | 46.80 |
| Net block | 44.21 | 21.79 | 16.03 |
| Capital work in progress | 0.00 | 0.00 | 0.00 |
| Investments | 0.03 | 0.00 | 0.06 |
| Inventories | 0.99 | 0.20 | 0.03 |
| Sundry debtors | 17.40 | 11.17 | 17.94 |
| Cash & bank balances | 6.44 | 7.12 | 3.42 |
| Loans & advances | 8.24 | 0.85 | 1.00 |
| Total current assets | 33.07 | 19.34 | 22.39 |
| Total current liabilities | 22.21 | 9.49 | 11.73 |
| Net working capital | 10.86 | 9.85 | 10.66 |
| Total assets | 71.40 | 46.95 | 37.05 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Opening cash | 5.87 | 0.80 | 3.14 |
| Net cash from operating activities | 25.39 | 22.12 | 9.85 |
| Net cash from investing activities | (30.63) | (14.66) | (1.38) |
| Net cash from financing activities | 5.73 | (2.39) | (10.81) |
| Net change in cash | 0.50 | 5.07 | (2.34) |
| Closing cash | 6.44 | 7.12 | 3.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Growth | |||
| Sales growth | +62.9% | +8.5% | - |
| EBITDA growth | +47.4% | +34.9% | - |
| PBT growth | +47.8% | +56.4% | +9997.0% |
| Net income growth | +57.4% | +59.3% | - |
| Profitability & leverage | |||
| Net income margin | +27.9% | +29.2% | +20.3% |
| Return on capital employed | +41.6% | +40.5% | +31.6% |
| Return on net worth | +39.1% | +36.8% | +28.9% |
| Debt / equity | 0.32 | 0.38 | 0.48 |
| Long-term debt / equity | 0.25 | 0.24 | 0.25 |
| Interest cover | 5.53 | 7.43 | 14.62 |
| Efficiency & per share | |||
| Fixed asset turnover | 0.87 | 0.74 | 0.75 |
| Inventory turnover | 104.69 | 332.52 | 1,174.33 |
| Debtors turnover | 4.36 | 2.63 | 1.96 |
| EPS (₹) | 10.41 | 85.87 | 5.40 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 31.84 | 278.57 | 19.27 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue | 62.29 | 38.24 | 35.23 |
| Revenue growth | +62.9% | +8.5% | - |
| Other income | 1.09 | 0.31 | 0.56 |
| Total expenses | 31.39 | 17.38 | 19.90 |
| Employee cost | 10.74 | 4.09 | 5.00 |
| EBITDA | 30.90 | 20.86 | 15.33 |
| EBITDA margin | +49.6% | +54.6% | +43.5% |
| Depreciation | 7.39 | 4.28 | 4.39 |
| Interest | 1.30 | 1.24 | 1.63 |
| Profit before tax | 23.30 | 15.65 | 9.87 |
| Tax | 5.92 | 4.64 | 3.00 |
| Net profit | 17.38 | 11.01 | 6.87 |
| Net profit margin | +27.9% | +28.8% | +19.5% |
| EPS (₹) | 10.41 | 85.63 | 5.35 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 16.69 | 1.28 | 1.28 |
| Reserves & surplus | 36.32 | 34.36 | 23.36 |
| Shareholders' funds (net worth) | 53.01 | 35.64 | 24.64 |
| Secured loans | 17.85 | 10.81 | 11.04 |
| Unsecured loans | 0.00 | 0.00 | 0.92 |
| Total debt | 17.85 | 10.81 | 11.96 |
| Total liabilities | 71.27 | 46.82 | 36.95 |
| Assets | |||
| Gross block | 86.65 | 56.84 | 46.80 |
| Net block | 44.21 | 21.79 | 16.03 |
| Capital work in progress | 0.00 | 0.00 | 0.00 |
| Investments | 0.03 | 0.38 | 0.38 |
| Inventories | 0.99 | 0.20 | 0.03 |
| Sundry debtors | 17.40 | 11.17 | 17.94 |
| Cash & bank balances | 6.44 | 7.12 | 3.42 |
| Loans & advances | 8.24 | 0.85 | 0.99 |
| Total current assets | 33.07 | 19.34 | 22.38 |
| Total current liabilities | 22.21 | 9.86 | 12.04 |
| Net working capital | 10.86 | 9.48 | 10.34 |
| Total assets | 71.27 | 46.82 | 36.95 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Opening cash | 5.87 | 0.80 | 3.14 |
| Net cash from operating activities | 25.39 | 22.18 | 10.00 |
| Net cash from investing activities | (30.63) | (14.72) | (1.53) |
| Net cash from financing activities | 5.73 | (2.39) | (10.81) |
| Net change in cash | 0.50 | 5.07 | (2.34) |
| Closing cash | 6.44 | 7.12 | 3.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Growth | |||
| Sales growth | +62.9% | +8.5% | - |
| EBITDA growth | +48.1% | +36.1% | - |
| PBT growth | +48.9% | +58.6% | +9997.0% |
| Net income growth | +57.9% | +60.3% | - |
| Profitability & leverage | |||
| Net income margin | +27.9% | +28.8% | +19.5% |
| Return on capital employed | +41.7% | +40.3% | +31.1% |
| Return on net worth | +39.2% | +36.5% | +27.9% |
| Debt / equity | 0.32 | 0.38 | 0.49 |
| Long-term debt / equity | 0.25 | 0.24 | 0.25 |
| Interest cover | 5.53 | 7.48 | 14.90 |
| Efficiency & per share | |||
| Fixed asset turnover | 0.87 | 0.74 | 0.75 |
| Inventory turnover | 104.69 | 332.52 | 1,174.33 |
| Debtors turnover | 4.36 | 2.63 | 1.96 |
| EPS (₹) | 10.41 | 85.63 | 5.35 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 31.76 | 277.53 | 19.19 |
To see the full year-wise statements and ratios of Pramodini Medicare Limited, buy the company report.
Board of directors of Pramodini Medicare Limited
Pramodini Medicare has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuldeep Chalasani Kumar Also directs: Khapra Diagnostics LLP, Rutvi Infra Private Limited, Vrisan Exports Private Limited and 4 more | Managing Director | 06 Apr 2015 | 11 Years 7 Months | Current |
| Kavitha Chalasani Also directs: Sri Ram Medicare Private Limited, Morpheus Sriram International Ivf Centre LLP, Lark Avenues Private Limited and 2 more | Director | 06 Apr 2015 | 11 Years 7 Months | Current |
| Manas Dash | Director | 01 Jan 2026 | 0 Years 10 Months | Current |
| Attaluri Ajay Kumar | Director | 01 Jan 2026 | 0 Years 10 Months | Current |
| Eshwar Chandra Nandury | Director | 01 Jan 2026 | 0 Years 10 Months | Current |
| Durga Aashritha Chalasani | Director | 05 Sep 2025 | 1 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jan 2026 | 101225580 | Hdfc Bank Limited | ₹16 Cr | Open | |
| 28 Jul 2025 | 101163127 | Others | ₹37.62 Lakh | Open | |
| 28 Jun 2025 | 101138863 | Others | ₹9.68 Cr | Open | |
| 31 May 2025 | 101114029 | Axis Bank Limited | ₹14.31 Cr | Open | |
| 07 Nov 2023 | 100812578 | Hdfc Bank Limited | ₹1.28 Cr | Open |
To see the full charge records of Pramodini Medicare Limited, buy the company report.
Total charge records: 18 View all charges
Deals & funding
Pramodini Medicare Limited has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹1.16 Cr; the latest was in August 2026.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Funding round | ₹25.5 Lakh | Investors: an individual |
| May 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Sri Ram Medicare Private Limited , an individual Seller: 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Sri Ram Medicare Private Limited , Infer Radiological and Imaging Services Private Limited Seller: 2 individuals |
| Dec 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
To see the full deal history of Pramodini Medicare Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pramodini Medicare Limited has 7 court cases on record: 2 filed by Pramodini Medicare, 5 filed against it. 1 case is pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 5 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed against the company by M/S. Asr Hospitals (India) Pvt. Ltd., | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed against the company by M/S. Asr Hospitals (India) Pvt. Ltd., | Disposed |
| High Court of Andhra Pradesh | Appeal | Filed against the company | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh, and 5 others | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed against the company by M/S.S L Diagnostic Pvt Ltd | Disposed |
To see the full case history of Pramodini Medicare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pramodini Medicare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pramodini Medicare has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCP0383J2ZA | Andhra Pradesh | Active | 27 Jun 2024 |
To see the full GST registrations and return filing status of Pramodini Medicare Limited, buy the company report.
Recent activity
Pramodini Medicare Limited has 12 board changes on record since 2015: 6 appointments and 6 cessations. The latest: Attaluri Ajay Kumar was appointed as Director on 01 Jan 2026.
31 earlier events are in the company report.
Frequently asked questions
Pramodini Medicare is an active public limited company based in Vijayawada, Andhra Pradesh, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 12 September 2000 (26+ years old) and is registered under CIN U85110AP2000PLC035231. Listed on NSE: PRAMODINI.
Pramodini Medicare reported revenue of ₹62.29 Cr for FY 2025-26 (up 62.9% YoY) based on consolidated financials.
Pramodini Medicare has 6 current directors:
- Kuldeep Chalasani Kumar - Managing Director
- Kavitha Chalasani - Director
- Manas Dash - Director
- Attaluri Ajay Kumar - Director
- Eshwar Chandra Nandury - Director
- Durga Aashritha Chalasani - Director
The latest financial statements of Pramodini Medicare on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pramodini Medicare is 37AACCP0383J2ZA, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pramodini Medicare is U85110AP2000PLC035231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Pramodini Medicare is a listed company as per MCA records. Its shares are listed on NSE (symbol: PRAMODINI).
Pramodini Medicare has 7 court cases on record: 2 filed by the company and 5 filed against it. 1 is pending.
Pramodini Medicare was incorporated on 12 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Vijayawada.
Pramodini Medicare has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 ipo), with disclosed funding of ₹1.16 Cr; the latest was in August 2026.

